These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

206 related items for PubMed ID: 9580386

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Lipoprotein(a) levels and isoforms and fibrinolytic activity in postmenopause--influence of hormone replacement therapy.
    Estellés A, Cano A, Falcó C, España F, Gilabert J, Grancha S, Aznar J.
    Thromb Haemost; 1999 Jan; 81(1):104-10. PubMed ID: 10348700
    [Abstract] [Full Text] [Related]

  • 4. Segregation analysis of plasma lipoprotein(a) levels in pedigrees with molecularly defined familial hypercholesterolemia.
    Friedlander Y, Leitersdorf E.
    Genet Epidemiol; 1995 Jan; 12(2):129-43. PubMed ID: 7607414
    [Abstract] [Full Text] [Related]

  • 5. Concentrations of the atherogenic Lp(a) are elevated in FH.
    Lingenhel A, Kraft HG, Kotze M, Peeters AV, Kronenberg F, Kruse R, Utermann G.
    Eur J Hum Genet; 1998 Jan; 6(1):50-60. PubMed ID: 9781014
    [Abstract] [Full Text] [Related]

  • 6. Elevated Lp(a) with a small apo(a) isoform in children: risk factor for the development of premature coronary artery disease.
    Dirisamer A, Widhalm H, Aldover-Macasaet E, Molzer S, Widhalm K.
    Acta Paediatr; 2008 Dec; 97(12):1653-7. PubMed ID: 18684164
    [Abstract] [Full Text] [Related]

  • 7. Sib-pair analysis detects elevated Lp(a) levels and large variation of Lp(a) concentration in subjects with familial defective ApoB.
    van der Hoek YY, Lingenhel A, Kraft HG, Defesche JC, Kastelein JJ, Utermann G.
    J Clin Invest; 1997 May 01; 99(9):2269-73. PubMed ID: 9151801
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of fibrinolysis by lipoprotein(a).
    Anglés-Cano E, de la Peña Díaz A, Loyau S.
    Ann N Y Acad Sci; 2001 May 01; 936():261-75. PubMed ID: 11460483
    [Abstract] [Full Text] [Related]

  • 9. Variation in lipoprotein(a) concentration associated with different apolipoprotein(a) alleles.
    Perombelon YF, Soutar AK, Knight BL.
    J Clin Invest; 1994 Apr 01; 93(4):1481-92. PubMed ID: 8163653
    [Abstract] [Full Text] [Related]

  • 10. Impact of apolipoprotein(a) isoform size heterogeneity on the lysine binding function of lipoprotein(a) in early onset coronary artery disease.
    Simó JM, Joven J, Vilella E, Ribas M, Pujana MA, Sundaram IM, Hammel JP, Hoover-Plow JL.
    Thromb Haemost; 2001 Mar 01; 85(3):412-7. PubMed ID: 11307806
    [Abstract] [Full Text] [Related]

  • 11. Does apolipoprotein(a) heterogeneity influence lipoprotein(a) effects on fibrinolysis?
    Hervio L, Chapman MJ, Thillet J, Loyau S, Anglés-Cano E.
    Blood; 1993 Jul 15; 82(2):392-7. PubMed ID: 8329699
    [Abstract] [Full Text] [Related]

  • 12. Characterization of the interaction of recombinant apolipoprotein(a) with modified fibrinogen surfaces and fibrin clots.
    Sangrar W, Koschinsky ML.
    Biochem Cell Biol; 2000 Jul 15; 78(4):519-25. PubMed ID: 11012092
    [Abstract] [Full Text] [Related]

  • 13. In vitro inhibition of fibrinolysis by apolipoprotein(a) and lipoprotein(a) is size- and concentration-dependent.
    Knapp JP, Herrmann W.
    Clin Chem Lab Med; 2004 Jul 15; 42(9):1013-9. PubMed ID: 15497466
    [Abstract] [Full Text] [Related]

  • 14. [Lipoprotein(a) concentrations and apolipoprotein(a) phenotype frequencies in cord blood of newborn infants and sera of children in Japan].
    Shimura Y, Tanaka T, Ohtani H.
    Rinsho Byori; 1997 Mar 15; 45(3):255-9. PubMed ID: 9086832
    [Abstract] [Full Text] [Related]

  • 15. Lipoprotein(a): a genetically determined lipoprotein containing a glycoprotein of the plasminogen family.
    Scanu AM.
    Semin Thromb Hemost; 1988 Jul 15; 14(3):266-70. PubMed ID: 2972066
    [Abstract] [Full Text] [Related]

  • 16. [Molecular patho-biochemistry and genetic diagnosis for plasminogen-apolipoprotein (a) gene family related to atherosclerosis and thrombosis].
    Ichinose A.
    Rinsho Byori; 1998 Dec 15; 46(12):1210-8. PubMed ID: 9916506
    [Abstract] [Full Text] [Related]

  • 17. [Familial hypercholesterolemia and plasma Lp(a) levels: 2 cardiovascular risk factors].
    Real JT, Romero G, Priego MA, Chaves FJ, Ascaso JF, Carmena R.
    An Med Interna; 1999 Feb 15; 16(2):69-72. PubMed ID: 10192997
    [Abstract] [Full Text] [Related]

  • 18. Impact of markedly elevated serum lipoprotein(a) levels (> or = 100 mg/dL) on the risk of coronary heart disease.
    Murase T, Okubo M, Amemiya-Kudo M, Hiraga T, Oka J, Shimada M, Igarashi T.
    Metabolism; 2007 Sep 15; 56(9):1187-91. PubMed ID: 17697860
    [Abstract] [Full Text] [Related]

  • 19. Apolipoprotein(a) isoform-specific changes of lipoprotein(a) after kidney transplantation.
    Kronenberg F, Lhotta K, König P, Margreiter R, Dieplinger H, Utermann G.
    Eur J Hum Genet; 2003 Sep 15; 11(9):693-9. PubMed ID: 12939656
    [Abstract] [Full Text] [Related]

  • 20. Absence of inhibition by lipoprotein (a) inhibition of tPA induced thrombolysis in a patient's plasma milieu.
    Lu H, Bruckert J, Soria J, Li H, de Gennes JL, Legrand A, Peynet J, Soria C.
    Blood Coagul Fibrinolysis; 1990 Oct 15; 1(4-5):513-6. PubMed ID: 1966796
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.